Great news from one of our PRECCO members. Medimaps Breaks New Ground in Fracture Risk Assessment with FDA Clearance and MDR Certification for TBS Osteo Next Generation Software

Medimaps Group, a global leader in AI-driven bone imaging solutions and proud PRECCO member, has achieved FDA 510(k) clearance and EU MDR certification for its latest version of its flagship Trabecular Bone Score (TBS) software, TBS Osteo.

The next-generation software of TBS Osteo is designed to enhance bone microarchitecture evaluation, broaden patient eligibility, and improve connectivity within medical facilities. By converting DXA scan data into precise, actionable reports, TBS Osteo complements bone mineral density measurements and clinical risk factors, providing clinicians with a comprehensive tool to assess osteoporotic fracture risks in patients. TBS Osteo is the only approved medical device software for evaluating bone microarchitecture in clinical settings. Since 2022 it has benefited from four Category

 

 

The Pre-Competitive Consortium on Osteoporosis and Bone Health (PRECCO) was created to support the five-year partnership signed between ESCEO and the World Health Organization to improve the management of osteoporosis, involving a diverse range of stakeholders, who place the osteoporotic patients at the centre of their priorities, independently of their immediate strategy, in terms of content and timeline.